About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The work of our group is mainly focused on personalized medicine, including chemical-functional stability studies of drugs in individualized preparations to be administered both orally and parenterally, as well as parenteral nutrition; research focused on the evaluation and/or design of population pharmacokinetic/pharmacodynamic (PK/PD) models and the characterization of the pharmacokinetics of certain drugs of therapeutic interest in the general population or in certain population groups; and research focused on pharmacogenetics and pharmacogenomics. Our research is also focused on advanced interventions: drug evaluation studies (effectiveness, safety and economic studies); and mobile health and telepharmacy.
PMID: 35779331 Journal: European Journal of Obstetrics & Gynecology and Re Year: 2022 Reference: Eur J Obstet Gynecol Reprod Biol. 2022 Aug;275:106-109. doi: 10.1016/j.ejogrb.2022.06.006. Epub 2022 Jun 20. Impact factor: 2.435 Publication type: Paper in international publication Authors: Poy, Maria Josep Cabanas; Bautista, Susana Clemente; Boix-Montanes, Antoni; Larrosa-Garcia, Maria; Jimenez-Lozano, Ines et al. DOI: 10.1016/j.ejogrb.2022.06.006
PMID: 34544604 Journal: MEDICINA CLINICA Year: 2022 Reference: Med Clin (Barc). 2022 Jun 10;158(11):509-518. doi: 10.1016/j.medcli.2021.06.012. Epub 2021 Jun 18. Impact factor: 1.725 Publication type: Paper in national publication Authors: Espinosa-Pereiro, Juan, Fernandez-Hidalgo, Nuria, Perez-Hoyos, Santiago, Salvador, Fernando, Dura, Xavier, Miarons, Marta, Anton, Andres, Eremiev-Eremiev, Simeon, Sempere-Gonzalez, Abiu, Monforte-Pallares, Arnau et al. DOI: 10.1016/j.medcli.2021.06.012
PMID: 35633061 Journal: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS Year: 2022 Reference: J Clin Pharm Ther. 2022 May 27. doi: 10.1111/jcpt.13704. Impact factor: 2.512 Publication type: Letter or abstract Authors: Garcia-Diaz, Hector C, Parramon-Teixido, Carlos J, Clemente-Batista, Susana, Jimenez-Lozano, Ines, Montaner-Ramon, Alicia, Del Toro, Mireia et al. DOI: 10.1111/jcpt.13704
PMID: 35620255 Journal: Clinical case reports Year: 2022 Reference: Clin Case Rep. 2022 May 23;10(5):e05848. doi: 10.1002/ccr3.5848. eCollection 2022 May. Impact factor: 0 Publication type: Letter or abstract Authors: Benitez Hidalgo, Olga, Martinez Garcia, M Fernanda, Bescos Cabestre, Agustin, Juarez Gimenez, Juan Carlos, Gironella Mesa, Mercedes, Bosch Albareda, Francesc et al. DOI: 10.1002/ccr3.5848
PMID: 33899648 Journal: LEUKEMIA & LYMPHOMA Year: 2021 Reference: Leuk Lymphoma. 2021 Sep;62(9):2288-2291. doi: 10.1080/10428194.2021.1913141. Epub 2021 Apr 24. Impact factor: 3.28 Publication type: Letter or abstract Authors: Carpio, Cecilia, Iacoboni, Gloria, Villacampa, Guillermo, Catala, Eva, Bobillo, Sabela, Perez, Ana, Jimenez, Moraima, Segura, Laura, Olive, Mireia, Farriols, Anna et al. DOI: 10.1080/10428194.2021.1913141
PMID: 33638257 Journal: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS Year: 2021 Reference: J Clin Pharm Ther. 2021 Aug;46(4):1062-1070. doi: 10.1111/jcpt.13394. Epub 2021 Feb 26. Impact factor: 2.512 Publication type: Paper in international publication Authors: Jimenez-Lozano, Ines, Caro-Teller, Jose Manuel, Fernandez-Hidalgo, Nuria, Miarons, Marta, Frick, Marie Antoinette, Batllori Badia, Emma, Serrano, Berta, Parramon-Teixido, Carlos Javier, Camba-Longueira, Fatima, Moral-Pumarega, Maria Teresa et al. DOI: 10.1111/jcpt.13394
PMID: 33095928 Journal: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS Year: 2021 Reference: J Clin Pharm Ther. 2021 Feb;46(1):50-65. doi: 10.1111/jcpt.13292. Epub 2020 Oct 23. Impact factor: 2.512 Publication type: Review in international publication Authors: Marta, Miarons, Maria, Roca, Francesc, Salva et al. DOI: 10.1111/jcpt.13292
Within the framework of a clinical trial, the first 3D printed medicine in Europe in the pediatric field will be tested.
